Tag: PaedNEO-VAX trial
Australia-based manufacturing to deliver custom mRNA vaccines for brain cancer trial
Southern RNA and Providence Therapeutics have announced their support for a world-first clinical trial evaluating personalised mRNA cancer vaccines for children with advanced and treatment-resistant brain tumours, in what the companies describe as a significant step for both clinical research and mRNA manufacturing capability.
Featured Article
Good Design Australia opens entries for 2026 awards
For more than six decades, Good Design Australia has celebrated the power of design to shape innovation, industry, and everyday life. Its flagship program, the Australian Good Design Awards, recognises projects that show how thoughtful design can enhance products, services, systems, and communities.
